Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3
- 16 October 2003
- journal article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 14 (3), 595-601
- https://doi.org/10.1016/j.nbd.2003.08.016
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramideThe FASEB Journal, 2002
- Enzyme Replacement Therapy of Infantile Gaucher DiseaseNeuropediatrics, 1993
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- Infantile gaucher's disease: A case with neuronal storageAnnals of Neurology, 1988
- Lysosphingolipids Inhibit Protein Kinase C: Implications for the SphingolipidosesScience, 1987
- Use of Activators and Inhibitors to Define the Properties of the Active Site of Normal and Gaucher Disease Lysosomal ß-GlucosidaseEnzyme, 1985
- Synthesis of 2-N-(Hexadecanoyl)-amino-4-nitrophenyl phosphorylcholine-hydroxide, a chromogenic substrate for assaying sphingomyelinase activityChemistry and Physics of Lipids, 1976
- Enzymatic synthesis of glucosylsphingosine by rat brain microsomesLipids, 1972
- Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease.JCI Insight, 1966
- Metabolism of glucocerebrosides II. Evidence of an enzymatic deficiency in Gaucher's diseaseBiochemical and Biophysical Research Communications, 1965